text
"['\n2. 연결재무제표\n가. 연결 재무상태표\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0연 결 재 무 상 태 표\n제34기 3분기 2022.09.30 현재\n제33기 \xa0 \xa0 \xa0 \xa0 \xa02021.12.31 현재\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과 목\n제34기 3분기\n제33기\n자산\n\u3000\n\u3000\nⅠ. 현금및현금성자산\n333,286,488,247\xa0\n530,221,533,537\xa0\nⅡ. 금융자산\n30,858,046,652,631\xa0\n31,028,040,694,514\xa0\n\xa0 1. 예치금\n364,340,082,202\xa0\n412,389,741,517\xa0\n\xa0 2. 당기손익인식금융자산\n1,084,620,106,313\xa0\n855,029,682,767\xa0\n\xa0 3. 매도가능금융자산\n6,981,168,257,097\xa0\n8,532,078,428,285\xa0\n\xa0 4. 만기보유금융자산\n14,146,808,982,790\xa0\n13,654,120,000,822\xa0\n\xa0 5. 위험회피목적파생상품자산\n0\xa0\n14,652,964,784\xa0\n\xa0 6. 대출채권\n7,985,934,164,527\xa0\n7,272,163,590,616\xa0\n\xa0 7. 수취채권\n295,175,059,702\xa0\n287,606,285,723\xa0\nⅢ. 관계기업투자자산\n259,051,565,665\xa0\n241,443,053,663\xa0\nⅣ. 유형자산\n70,151,382,465\xa0\n64,681,463,263\xa0\nⅤ. 투자부동산\n276,678,056,100\xa0\n286,264,329,741\xa0\nⅥ. 무형자산\n23,045,771,993\xa0\n22,081,103,534\xa0\nⅦ. 기타자산\n983,842,972,878\xa0\n763,426,417,692\xa0\n\xa0 1. 재보험자산\n20,331,553,937\xa0\n23,329,596,564\xa0\n\xa0 2. 미상각신계약비\n630,756,026,767\xa0\n676,785,821,647\xa0\n\xa0 3. 순확정급여자산\n9,960,372,851\xa0\n3,331,115,157\xa0\n\xa0 4. 당기법인세자산\n59,817,429,487\xa0\n55,213,993,626\xa0\n\xa0 5. 이연법인세자산\n255,279,249,596\xa0\n0\xa0\n\xa0 6. 그밖의기타자산\n7,698,340,240\xa0\n4,765,890,698\xa0\nⅧ. 특별계정자산\n3,734,601,505,016\xa0\n4,167,186,093,858\xa0\n자산 총계\n36,538,704,394,995\xa0\n37,103,344,689,802\xa0\n부채\n\u3000\n\u3000\nⅠ. 보험계약부채\n29,319,787,036,638\xa0\n28,677,157,681,678\xa0\nⅡ. 계약자지분조정\n591,434,960\xa0\n10,536,871,847\xa0\nⅢ. 금융부채\n1,252,603,814,706\xa0\n566,908,706,425\xa0\n\xa0 1. 당기손익인식금융부채\n2,804,539,001\xa0\n5,754,630,208\xa0\n\xa0 2. 상각후취득원가측정금융부채\n370,631,310,207\xa0\n378,629,758,306\xa0\n\xa0 3. 위험회피목적파생상품부채\n879,167,965,498\xa0\n182,524,317,911\xa0\nⅣ. 기타부채\n232,908,764,255\xa0\n431,045,816,306\xa0\n\xa0 1. 충당부채\n63,762,181,343\xa0\n55,205,476,217\xa0\n\xa0 2. 순확정급여부채\n641,737,599\xa0\n\u3000\n\xa0 3. 이연법인세부채\n0\xa0\n95,437,366,375\xa0\n\xa0 4. 그밖의기타부채\n168,504,845,313\xa0\n280,402,973,714\xa0\nⅤ. 특별계정부채\n3,902,968,053,640\xa0\n4,373,759,721,781\xa0\n부채 총계\n34,708,859,104,199\xa0\n34,059,408,798,037\xa0\n자본\n\u3000\n\u3000\nⅠ. 지배주주지분\n1,829,845,290,796\xa0\n3,043,935,891,765\xa0\n\xa0 1. 자본금\n806,792,925,000\xa0\n806,792,925,000\xa0\n\xa0 2. 자본잉여금\n463,680,391,349\xa0\n463,680,391,349\xa0\n\xa0 3. 신종자본증권\n344,619,036,991\xa0\n344,619,036,991\xa0\n\xa0 4. 자본조정\n-60,806,002,790\xa0\n-60,806,002,790\xa0\n\xa0 5. 기타포괄손익누계액\n-1,063,063,996,864\xa0\n177,612,835,170\xa0\n\xa0 6. 이익잉여금\n1,338,622,937,110\xa0\n1,312,036,706,045\xa0\n\xa0 \xa0 \xa0 \xa0대손준비금기적립액\n69,408,741,025\xa0\n66,862,523,207\xa0\n\xa0 \xa0 \xa0 \xa0대손준비금적립예정액\n3,079,809,691\xa0\n2,546,217,818\xa0\nⅡ. 비지배지분\n0\xa0\n0\xa0\n자본 총계\n1,829,845,290,796\xa0\n3,043,935,891,765\xa0\n부채 및 자본 총계\n36,538,704,394,995\xa0\n37,103,344,689,802\xa0\n나. 연결포괄손익계산서 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 연 결 포 괄 손 익 계 산 서\n제34기 3분기 \xa02022.01.01 ~ 2022.09.30\n제33기 3분기 \xa02021.01.01 ~ 2021.09.30\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과 목\n제34기 3분기\n제33기 3분기\nⅠ. 영업수익\n6,409,156,070,569\xa0\n5,038,352,236,367\xa0\n\xa0 1. 보험료수익\n4,177,279,798,404\xa0\n3,387,572,609,546\xa0\n\xa0 2. 재보험수익\n50,892,713,600\xa0\n57,744,004,801\xa0\n\xa0 3. 이자수익\n639,514,076,587\xa0\n614,689,632,401\xa0\n\xa0 4. 배당수익\n86,602,405,292\xa0\n94,188,913,255\xa0\n\xa0 5. 금융상품거래이익\n96,630,586,864\xa0\n231,754,925,384\xa0\n\xa0 6. 금융상품평가이익\n6,154,601,924\xa0\n7,915,416,830\xa0\n\xa0 7. 수수료수익\n11,513,269,899\xa0\n6,154,864,731\xa0\n\xa0 8. 외환거래이익\n1,229,054,298,165\xa0\n544,161,785,450\xa0\n\xa0 9. 기타영업수익\n14,556,081,204\xa0\n15,543,454,423\xa0\n\xa0 10. 특별계정수입수수료\n29,053,193,437\xa0\n31,081,790,148\xa0\n\xa0 11. 특별계정수익\n67,905,045,193\xa0\n47,544,839,398\xa0\nⅡ. 영업비용\n6,179,652,440,360\xa0\n4,734,272,508,109\xa0\n\xa0 1. 보험계약부채전입액\n645,627,397,587\xa0\n237,217,096,509\xa0\n\xa0 2. 보험금비용\n3,594,755,726,301\xa0\n3,194,034,396,573\xa0\n\xa0 3. 재보험비용\n49,718,518,343\xa0\n61,223,260,423\xa0\n\xa0 4. 사업비\n276,282,431,246\xa0\n250,411,645,742\xa0\n\xa0 5. 신계약비상각비\n217,044,584,534\xa0\n250,317,489,711\xa0\n\xa0 6. 재산관리비\n26,379,292,519\xa0\n31,505,971,438\xa0\n\xa0 7. 이자비용\n10,611,988,896\xa0\n10,629,503,802\xa0\n\xa0 8. 금융상품거래손실\n447,156,919,964\xa0\n222,428,125,622\xa0\n\xa0 9. 금융상품평가손실\n830,126,308,394\xa0\n411,618,021,273\xa0\n\xa0 10. 외환거래손실\n2,243,254,700\xa0\n3,814,967,234\xa0\n\xa0 11. 기타영업비용\n11,632,117,314\xa0\n13,132,899,900\xa0\n\xa0 12. 특별계정지급수수료\n168,855,369\xa0\n394,290,484\xa0\n\xa0 13. 특별계정비용\n67,905,045,193\xa0\n47,544,839,398\xa0\nⅢ. 영업이익\n229,503,630,209\xa0\n304,079,728,258\xa0\nⅣ. 영업외수익\n2,424,064,756\xa0\n18,196,218,851\xa0\nⅤ. 영업외비용\n41,883,426,155\xa0\n5,350,478,670\xa0\nⅥ. 법인세비용차감전순이익\n190,044,268,810\xa0\n316,925,468,439\xa0\nⅦ. 법인세비용\n46,726,715,021\xa0\n67,144,785,068\xa0\nⅧ. 연결분기순이익\n143,317,553,789\xa0\n249,780,683,371\xa0\n\xa0 1. 지배주주지분순이익\n143,317,553,789\xa0\n249,780,683,371\xa0\n\xa0 2. 비지배주주지분순이익\n0\xa0\n0\xa0\nⅨ. 연결기타포괄손익\n-1,240,676,832,034\xa0\n-243,358,645,478\xa0\n\xa0 1. 후속적으로 당기손익으로 재분류될 수 있는 포괄손익\n-1,248,709,452,769\xa0\n-246,262,378,049\xa0\n\xa0 \xa0 (1) 매도가능금융자산평가손익\n-1,087,981,842,483\xa0\n-217,774,978,871\xa0\n\xa0 \xa0 (2) 만기보유금융자산평가손익\n-6,001,649,094\xa0\n-10,995,134,084\xa0\n\xa0 \xa0 (3) 현금흐름위험회피파생상품평가손익\n-40,127,962,432\xa0\n-1,551,774,587\xa0\n\xa0 \xa0 (4) 특별계정기타포괄손익\n-114,597,998,760\xa0\n-15,940,490,507\xa0\n\xa0 2. 후속적으로 당기손익으로 재분류되지 않는 포괄손익\n8,032,620,735\xa0\n2,903,732,571\xa0\n\xa0 \xa0 (1) 재평가잉여금\n15,976,684\xa0\n23,649,129\xa0\n\xa0 \xa0 (2) 순확정급여부채의 재측정요소\n8,016,644,051\xa0\n2,880,083,442\xa0\nⅩ. 연결총포괄손익\n-1,097,359,278,245\xa0\n6,422,037,893\xa0\n\xa0 1. 지배주주지분총포괄손익\n-1,097,359,278,245\xa0\n6,422,037,893\xa0\n\xa0 2. 비지배주주지분총포괄손익\n0\xa0\n0\xa0\n기본 및 희석주당이익\n920\xa0\n1,603\xa0\n다. 연결현금흐름표\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 연 결 현 금 흐 름 표\n제34기 3분기 \xa02022.01.01 ~ 2022.09.30\n제33기 3분기 \xa02021.01.01 ~ 2021.09.30\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n제34기 3분기\n제33기 3분기\nⅠ. 영업활동으로 인한 현금흐름\n-365,211,208,942\xa0\n608,778,859,983\xa0\n\xa0 1. 연결분기순이익\n143,317,553,789\xa0\n249,780,683,371\xa0\n\xa0 2. 손익조정항목\n231,287,644,588\xa0\n-245,833,872,422\xa0\n\xa0 3. 자산ㆍ부채의 변동\n-1,359,533,457,432\xa0\n7,360,391,703\xa0\n\xa0 4. 이자수취액\n583,788,554,376\xa0\n519,504,596,671\xa0\n\xa0 5. 이자지급액\n-8,140,437,759\xa0\n-8,020,046,839\xa0\n\xa0 6. 배당금수취액\n86,602,405,292\xa0\n94,186,537,435\xa0\n\xa0 7. 법인세납부액\n-42,533,471,796\xa0\n-8,199,429,936\xa0\nⅡ. 투자활동으로 인한 현금흐름\n293,233,556,735\xa0\n-658,266,565,051\xa0\n\xa0 1. 매도가능금융자산의 취득\n-1,261,266,790,970\xa0\n-3,350,864,157,159\xa0\n\xa0 2. 매도가능금융자산의 처분\n1,862,360,826,660\xa0\n3,359,875,407,192\xa0\n\xa0 3. 만기보유금융자산의 취득\n-416,651,872,120\xa0\n-816,383,958,655\xa0\n\xa0 4. 만기보유금융자산의 상환\n560,494,639,305\xa0\n121,581,155,103\xa0\n\xa0 5. 위험회피목적파생상품자산의 정산\n-399,137,904,612\xa0\n26,082,339,346\xa0\n\xa0 6. 관계기업투자자산의 취득\n-50,000,000,000\xa0\n0\xa0\n\xa0 7. 유형자산의 취득\n-1,495,980,864\xa0\n-1,409,382,010\xa0\n\xa0 8. 유형자산의 처분\n174,458,491\xa0\n89,274,032\xa0\n\xa0 9. 무형자산의 취득\n-1,157,651,655\xa0\n-514,954,000\xa0\n\xa0 10. 무형자산의 처분\n0\xa0\n1,980,000,000\xa0\n\xa0 11. 임차보증금의 증가\n-2,021,032,660\xa0\n-1,367,601,700\xa0\n\xa0 12. 임차보증금의 감소\n1,934,865,160\xa0\n2,665,312,800\xa0\nⅢ. 재무활동으로 인한 현금흐름\n-126,606,910,681\xa0\n-60,893,916,170\xa0\n\xa0 1. 배당금의 지급\n-96,632,322,700\xa0\n-34,288,888,700\xa0\n\xa0 2. 임대보증금의 증가\n268,450,000\xa0\n297,168,000\xa0\n\xa0 3. 임대보증금의 감소\n-980,502,000\xa0\n-95,837,000\xa0\n\xa0 4. 리스부채 원금 지급\n-9,163,535,957\xa0\n-8,665,114,720\xa0\n\xa0 5. 신종자본증권 배당\n-20,099,000,024\xa0\n-18,141,243,750\xa0\nⅣ. 외화표시 현금및현금성자산에 대한 환율변동효과\n1,649,517,598\xa0\n3,985,448\xa0\nⅤ. 현금및현금성자산의 감소(Ⅰ+Ⅱ+Ⅲ+Ⅳ)\n-196,935,045,290\xa0\n-110,377,635,790\xa0\nⅥ. 기초의 현금및현금성자산\n530,221,533,537\xa0\n263,026,074,025\xa0\nⅦ. 분기말의 현금및현금성자산\n333,286,488,247\xa0\n152,648,438,235\xa0\n라. 연결자본변동표 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 연 결 자 본 변 동 표\n제34기 3분기 \xa02022.01.01 ~ 2022.09.30\n제33기 3분기 \xa02021.01.01 ~ 2021.09.30\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과목\n자본금\n연결자본잉여금\n신종자본증권\n연결자본조정\n연결기타포괄 손익누계액\n연결이익잉여금\n지배주주지분소계\n비지배지분\n총계\n2021년 1월 1일 (전기초)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n426,769,685,838\n1,111,438,064,456\n3,092,494,100,844\n-\n3,092,494,100,844\n\xa0 회계정책변경효과\n-\n-\n-\n-\n-\n-22,590,021,687\n-22,590,021,687\n-\n-22,590,021,687\n2021년 1월 1일 (조정 후)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n426,769,685,838\n1,088,848,042,769\n3,069,904,079,157\n-\n3,069,904,079,157\n자본에 직접 반영된 소유주와의 거래 등 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 연차배당\n-\n-\n-\n-\n-\n-34,288,888,700\n-34,288,888,700\n-\n-34,288,888,700\n\xa0 신종자본증권배당\n-\n-\n-\n-\n-\n-18,141,243,750\n-18,141,243,750\n-\n-18,141,243,750\n연결총포괄이익 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 연결분기순이익\n-\n-\n-\n-\n-\n249,780,683,371\n249,780,683,371\n-\n249,780,683,371\n\xa0 매도가능금융자산평가손익\n-\n-\n-\n-\n-217,774,978,871\n-\n-217,774,978,871\n-\n-217,774,978,871\n\xa0 만기보유금융자산평가손익\n-\n-\n-\n-\n-10,995,134,084\n-\n-10,995,134,084\n-\n-10,995,134,084\n\xa0 현금흐름위험회피파생상품평가손익\n-\n-\n-\n-\n-1,551,774,587\n-\n-1,551,774,587\n-\n-1,551,774,587\n\xa0 특별계정기타포괄손익\n-\n-\n-\n-\n-15,940,490,507\n-\n-15,940,490,507\n-\n-15,940,490,507\n\xa0 재평가잉여금\n-\n-\n-\n-\n23,649,129\n-\n23,649,129\n-\n23,649,129\n\xa0 확정급여제도의 재측정요소\n-\n-\n-\n-\n2,880,083,442\n-\n2,880,083,442\n-\n2,880,083,442\n2021년 9월 30일 (전분기말)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n183,411,040,360\n1,286,198,593,690\n3,023,895,984,600\n-\n3,023,895,984,600\n2022년 1월 1일 (당기초)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n177,612,835,170\n1,312,036,706,045\n3,043,935,891,765\n-\n3,043,935,891,765\n자본에 직접 반영된 소유주와의 거래 등 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 연차배당\n-\n-\n-\n-\n-\n-96,632,322,700\n-96,632,322,700\n-\n-96,632,322,700\n\xa0 신종자본증권배당\n-\n-\n-\n-\n-\n-20,099,000,024\n-20,099,000,024\n-\n-20,099,000,024\n연결총포괄손익 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 연결분기순이익\n-\n-\n-\n-\n-\n143,317,553,789\n143,317,553,789\n-\n143,317,553,789\n\xa0 매도가능금융자산평가손익\n-\n-\n-\n-\n-1,087,981,842,483\n-\n-1,087,981,842,483\n-\n-1,087,981,842,483\n\xa0 만기보유금융자산평가손익\n-\n-\n-\n-\n-6,001,649,094\n-\n-6,001,649,094\n-\n-6,001,649,094\n\xa0 현금흐름위험회피파생상품평가손익\n-\n-\n-\n-\n-40,127,962,432\n-\n-40,127,962,432\n-\n-40,127,962,432\n\xa0 특별계정기타포괄손익\n-\n-\n-\n-\n-114,597,998,760\n-\n-114,597,998,760\n-\n-114,597,998,760\n\xa0 재평가잉여금\n-\n-\n-\n-\n15,976,684\n-\n15,976,684\n-\n15,976,684\n\xa0 확정급여제도의 재측정요소\n-\n-\n-\n-\n8,016,644,051\n-\n8,016,644,051\n-\n8,016,644,051\n2022년 9월 30일 (당분기말)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n-1,063,063,996,864\n1,338,622,937,110\n1,829,845,290,796\n-\n1,829,845,290,796\n']"
